Intravitreal Corticosteroids in the Management of Diabetic Macular Edema.

  title={Intravitreal Corticosteroids in the Management of Diabetic Macular Edema.},
  author={Stephen G Schwartz and Harry W. Flynn and Ingrid U. Scott},
  journal={Current ophthalmology reports},
  volume={1 3}
Diabetic macular edema (DME) remains an important worldwide cause of visual loss. Corticosteroids have a role in the treatment of some patients with advanced or recurrent DME. The best studied steroids for this indication are triamcinolone acetonide, dexamethasone, and fluocinolone acetonide. All steroids are associated with risks of cataract and intraocular pressure elevation. In addition, intravitreal injection of any medication is associated with risks of infectious endophthalmitis, which… CONTINUE READING
11 Citations
52 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 11 extracted citations


Publications referenced by this paper.
Showing 1-10 of 52 references

Diabetic Retinopathy

  • Network, J Googe, AJ Brucker
  • Curr Ophthalmol Rep
  • 2013

Similar Papers

Loading similar papers…